title: [Metabolic pathway and metabolites of pseudolaric acid B].
abstract: The metabolic profile of pseudolaric acid B (PB) was investigated by using in vivo and in vitro tests. Pseudolaric acid C2 (PC2) was identified as the specific metabolite of PB in plasma, urine, bile and feces using HPLC and HPLC-ESI/MS(n) after both oral and intravenous administration to rats, and almost no prototype was detected in all kinds of samples. The metabolic behaviors of PB orally administered in rats treated with antibiotics to eliminate intestinal microflora were identical with those in untreated rats, demonstrating that the metabolism of PB is independent of intestinal microflora. PB was stable in 48 h respective incubation with artificial gastric juice and artificial intestinal juice, suggesting that neither pepsin nor trypsin is in charge of metabolism of PB, and also demonstrating that PB is stable in both pH environments of gastric tract and intestinal tract. In vitro research on metabolism of PB in rat liver microsomes incubation revealed that little PB was metabolized and that the proposed metabolites were the demethoxy and demethoxydecarboxy products of the prototype. The amount of metabolites was extremely low compared with the prototype, indicating that liver microsomes are not responsible for the metabolism of PB either. PB was gradually metabolized into PC2 during 1 h in whole blood incubation in vitro, and the metabolic process showed dynamically dependent manner with incubation time. Once absorbed into blood, PB was quickly metabolized into PC2, accordingly, little prototype was detected in all kinds of samples. The metabolism was attributed to the rapid hydrolysis of C-19 ester bond by plasma esterase. These results clarified the metabolic pathway of PB for the first time, which was of great significance to identify the in vivo active form and interpret acting mechanism of the active compounds of P. kaempferi.
authors.affiliation: Department of Natural Medicines, School of Pharmaceutical Sciences, Peking University Health Science Center, Beijing 100083, China.
authors.forename: Peng
authors.initials: P
authors.lastname: Liu
authors.forename: Man
authors.initials: M
authors.lastname: Xu
authors.forename: Hong-zhu
authors.initials: HZ
authors.lastname: Guo
authors.forename: Jiang-hao
authors.initials: JH
authors.lastname: Sun
authors.forename: Hui
authors.initials: H
authors.lastname: Guo
authors.forename: Shi-feng
authors.initials: SF
authors.lastname: Sun
authors.forename: De-an
authors.initials: DA
authors.lastname: Guo
mesh_terms: D061605:Administration, Intravenous; D000284:Administration, Oral; D000818:Animals; D001646:Bile / Q000378:metabolism; D004224:Diterpenes / Q000097:blood / Q000378:metabolism* / Q000652:urine; D004950:Esterases / Q000378:metabolism; D005243:Feces / Q000737:chemistry; D006868:Hydrolysis; D008297:Male; D053858:Metabolic Networks and Pathways; D008862:Microsomes, Liver / Q000378:metabolism; D028201:Pinaceae / Q000737:chemistry*; D024301:Plant Bark / Q000737:chemistry; D010946:Plants, Medicinal / Q000737:chemistry; D051381:Rats; D017207:Rats, Sprague-Dawley
chemical_list: D004224:Diterpenes; C058391:pseudolaric acid B; D004950:Esterases